| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 280,600 | 357,000 | 380,700 | 390,300 | | Cost of Revenue | 178,600 | 220,300 | 230,000 | 249,700 | | | Gross Profit | 102,000 | 136,700 | 150,700 | 140,600 | | | Operating Expenses | | Research Development | 42,700 | 42,900 | 45,100 | 47,500 | | Selling General and Administrative | 93,800 | 105,000 | 112,300 | 137,900 | | Non Recurring | 63,000 | 703,400 | 2,800 | 45,600 | | Others | 6,700 | 6,900 | 7,100 | 8,000 | | | | Total Operating Expenses | 206,200 | 858,200 | 167,300 | 239,000 | | | | Operating Income or Loss | (104,200) | (721,500) | (16,600) | (98,400) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 20,300 | 16,600 | 3,200 | 70,500 | | Earnings Before Interest And Taxes | (83,900) | (704,900) | (13,400) | (27,900) | | Interest Expense | 1,900 | 2,100 | 2,000 | 2,100 | | Income Before Tax | (85,800) | (707,000) | (15,400) | (30,000) | | Income Tax Expense | (600) | (1,700) | 1,000 | (200) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (85,200) | (705,300) | (16,400) | (29,800) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (85,200) | (705,300) | (16,400) | (29,800) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($85,200) | ($705,300) | ($16,400) | ($29,800) |
|
0.45% Nasdaq 
0.20%
Income Statement
